Columbia Research Enhanced Value ETF

Columbia Research Enhanced Value ETF (REVS) is an index fund that tracks the Beta Advantage Research Enhanced U.S. Value Index. That index is a rules-based subset of the Russell 1000 Value Index, picked using quality, value and company catalyst factors. Its 0.19% expense ratio matches iShares Russell 1000 Value ETF (IWD) but is above some rivals. With $334 million in net assets as of July 31, 2026, it is smaller than most similar funds.

• Over the year to Oct 27, 2026, REVS returned +22.2%, 7th of 9 among similar funds.
• Its 5-year annualized return was +12.6%.
• In the 2020 COVID crash it fell 37.6% and regained its old high 9.3 months after the low.
• Its worst full calendar year was 2022 (-6.2%); its best was 2021 (+28.5%).
• The deepest fall in its price history was 37.9% (Feb 12, 2020 to Mar 23, 2020), recovered by Jan 6, 2021.

As of Jul 31, 2026, the fund held 303 securities; the ten largest made up 32.52% of assets.

By sector

• Over the three months to Jul 31, 2026, investors added a net $26.6M (creations minus redemptions, per the N-PORT report).
• Monthly total returns reported for that quarter: +2.31%, -0.13%, +5.40%.

REVS is an index fund. It aims to match the Beta Advantage Research Enhanced U.S. Value Index, before fees and expenses. That index starts with the Russell 1000 Value Index, which tracks U.S. large- and mid-sized companies whose shares look cheap relative to measures like earnings. Fixed rules then keep only some of those companies, scoring each one on quality, value and what the prospectus calls "company catalyst" factors. Columbia Management Investment Advisers, the fund's own adviser, designed the index. FTSE Russell calculates it.

The index usually holds 250 to 290 stocks but has no fixed count. The fund had 303 holdings as of July 31, 2026. The index resets its membership and weights twice a year, in June and December. The fund aims to own nearly every stock in the index in similar proportions, though it may hold only a sample. Portfolio turnover, the share of the portfolio traded over a year, was 69%, according to the prospectus filed February 26, 2026.

The adviser does no company research and makes no market calls. The fund will not move to cash in a downturn. The index has no sector limits, and as of October 31, 2025, it was concentrated in financial services. As of July 31, 2026, the largest holdings were Apple (8.0%) and Microsoft (6.8%), and the top 10 holdings made up 32.5% of assets.

• REVS charges 0.19% a year, versus an average of 0.25% for the similar funds below (5th of 9, cheapest first).
• The fee includes a 0.01% waiver from the adviser, which may end.
• Using the prospectus's standard example, $10,000 invested would cost about $19 in the first year and $254 over 10 years (assuming a 5% annual return).

It offers a low-cost, rules-based basket of about 300 US large and mid-size stocks, tilted toward value companies, that could form the US stock part of a portfolio.

REVS could fill the US stock slot in a long-term portfolio and add a tilt toward value companies. Its record is short. It launched in September 2019, so it has no 2008 history. In the 2020 COVID crash it fell 37.6% in about a month and took roughly nine months to recover. In 2022 it fell 18% from April to September and took about 9.6 months to recover. Its full-year 2022 loss of 5.82% was its worst calendar year. Selling in a slump like early 2020 would have locked in steep losses. Income is modest: the trailing yield was 1.76% as of October 27, 2026, paid once a year. Costs are low. The SEC's standard example puts them at $19 in year one and $254 over 10 years on $10,000. Past results don't predict future ones, and a plan should look at the whole portfolio, not one fund.

Matched by holdings overlap from the latest N-PORT reports.